Christian Peifer

Title: Innovations in Angiogenesis Inhibition by Inventor Christian Peifer

Introduction

Christian Peifer, an accomplished inventor based in Tübingen, Germany, has made significant contributions to the field of medicinal chemistry. He is recognized for his innovative work in the development of compounds aimed at controlling angiogenesis, a critical biological process in both health and disease. Peifer's groundbreaking invention focuses on a specific class of compounds that have the potential to serve as angiogenesis inhibitors.

Latest Patents

Among his achievements, Christian Peifer holds a notable patent titled “3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors.” This patent describes a compound represented by the formula (I), which encompasses a variety of possible substituents that may influence the compound's pharmacological properties. The invention details the composition of the compounds, including R groups that can be a range of alkyl, phenyl, or substituted phenyl structures, and indicates their physiologically acceptable salts and solvates. These compounds show promise as therapeutic agents for controlling angiogenesis, making them valuable in treating various medical conditions.

Career Highlights

Christian Peifer is affiliated with Johannes Gutenberg University, where he continues to advance his research and contribute to the academic community. With a focus on the medicinal applications of his innovations, he has carved out a niche regarding the synthesis and application of novel angiogenesis inhibitors. Peifer's patent represents the culmination of extensive research and experimentation aimed at addressing significant challenges in medicine.

Collaborations

Throughout his career, Peifer has collaborated with accomplished professionals in the field, including Gerd Dannhardt and Stanislav Plutizki. These partnerships have been instrumental in enhancing the scope and impact of his research initiatives, fostering a collaborative environment that thrives on sharing ideas and expertise.

Conclusion

In summary, Christian Peifer has made a noteworthy impact in the field of medicinal chemistry with his innovative approach to angiogenesis inhibition. His patent highlights the potential for new therapeutic compounds that could play crucial roles in medical advancements. As he continues his work with Johannes Gutenberg University, the medical community eagerly anticipates further developments from Peifer and his collaborators in the realm of innovative therapeutic solutions.